| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Ricardo Durães-Carvalho | Q54377967 |
| Renato A.S. Oliveira | Q60324625 | ||
| P2093 | author name string | Edmilson F de Oliveira-Filho | |
| Renato A S Oliveira | |||
| Laura H V G Gil | |||
| José V J Silva | |||
| Thaísa R R Lopes | |||
| Louisa F Ludwig-Begall | |||
| Ricardo Durães-Carvalho | |||
| Daisy E A Silva | |||
| Daisy E.A. Silva | |||
| Edmilson F. de Oliveira-Filho | |||
| José V.J. Silva | |||
| Laura H.V.G. Gil | |||
| Louisa F. Ludwig-Begall | |||
| Thaísa R.R. Lopes | |||
| P2860 | cites work | A single mutation in chikungunya virus affects vector specificity and epidemic potential | Q21131599 |
| Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak | Q21144706 | ||
| Novel chikungunya vaccine candidate with an IRES-based attenuation and host range alteration mechanism | Q21559402 | ||
| Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study | Q21562246 | ||
| Post-epidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period | Q21562272 | ||
| Declining malaria, rising of dengue and Zika virus: insights for mosquito vector control | Q24261438 | ||
| Extended Preclinical Safety, Efficacy and Stability Testing of a Live-attenuated Chikungunya Vaccine Candidate | Q24276430 | ||
| Mosquitoes as Suitable Vectors for Alphaviruses | Q50002141 | ||
| Transgenic Mosquitoes - Fact or Fiction? | Q51148295 | ||
| Role of monkeys in the sylvatic cycle of chikungunya virus in Senegal. | Q52657326 | ||
| Current Strategies for Inhibition of Chikungunya Infection. | Q54214355 | ||
| Managing Aedes aegypti populations in the first Zika transmission zones in the continental United States | Q56342256 | ||
| [Chikungunya in paediatrics: epidemic of 2005-2006 in Saint-Denis, Reunion Island] | Q80823931 | ||
| Managing mosquitoes and ticks in a rapidly changing world - Facts and trends | Q91865576 | ||
| Ophthalmologic aspects of chikungunya infection | Q24278918 | ||
| Chikungunya virus transmission potential by local Aedes mosquitoes in the Americas and Europe | Q24288753 | ||
| Emergence and potential for spread of Chikungunya virus in Brazil | Q24288877 | ||
| Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages | Q24288996 | ||
| Factors responsible for the emergence of arboviruses; strategies, challenges and limitations for their control | Q24289350 | ||
| Chikungunya, an epidemic arbovirosis | Q24291001 | ||
| Chikungunya virus infection | Q24497757 | ||
| Re-emergence of Chikungunya and O'nyong-nyong viruses: evidence for distinct geographical lineages and distant evolutionary relationships | Q24570057 | ||
| Molecular diagnosis and analysis of Chikungunya virus | Q24575474 | ||
| Persistent arthralgia induced by Chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor | Q24625887 | ||
| A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection | Q24631774 | ||
| Chikungunya risk for Brazil | Q24701737 | ||
| Chikungunya virus in the Americas--what a vectorborne pathogen can do | Q24701742 | ||
| Detection of chikungunya virus antigen by a novel rapid immunochromatographic test | Q24701756 | ||
| Early Events in Chikungunya Virus Infection-From Virus Cell Binding to Membrane Fusion | Q24701760 | ||
| DNA vaccine initiates replication of live attenuated chikungunya virus in vitro and elicits protective immune response in mice | Q24701765 | ||
| Reemergence of chikungunya virus | Q24701780 | ||
| Multiple immune factors are involved in controlling acute and chronic chikungunya virus infection | Q24701792 | ||
| Co-distribution and co-infection of chikungunya and dengue viruses | Q24701811 | ||
| Zika, Dengue and Chikungunya Co-Infection in a Pregnant Woman from Colombia | Q26248932 | ||
| Time to Empower Release of Insects Carrying a Dominant Lethal and Wolbachia Against Zika | Q26314587 | ||
| Vertical transmission of Indian Ocean Lineage of chikungunya virus in Aedes aegypti and Aedes albopictus mosquitoes | Q26315524 | ||
| Congenital Chikungunya Virus Infection after an Outbreak in Salvador, Bahia, Brazil | Q26698763 | ||
| Neonatal encephalitis due to Chikungunya vertical transmission: First report in Brazil | Q26700011 | ||
| Chikungunya: bending over the Americas and the rest of the world | Q26771903 | ||
| Biological Control of Mosquito Vectors: Past, Present, and Future | Q27135029 | ||
| The Newala epidemic. III. The virus: isolation, pathogenic properties and relationship to the epidemic | Q27469278 | ||
| Chikungunya Fever in Travelers Returning to Europe from the Indian Ocean Region, 2006 | Q27487088 | ||
| Chimeric alphavirus vaccine candidates for chikungunya | Q27487105 | ||
| Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus | Q27487330 | ||
| Guillain-Barré Syndrome after Chikungunya Infection | Q27488380 | ||
| Combining the Sterile Insect Technique with Wolbachia-Based Approaches: II--A Safer Approach to Aedes albopictus Population Suppression Programmes, Designed to Minimize the Consequences of Inadvertent Female Release | Q35739790 | ||
| Antiviral activity of silymarin against chikungunya virus | Q35745203 | ||
| Chikungunya virus, southeastern France | Q35876743 | ||
| A single point mutation controls the cholesterol dependence of Semliki Forest virus entry and exit | Q36254866 | ||
| The biological control of the malaria vector | Q36329669 | ||
| Inactivation of Chikungunya virus by 1,5 iodonapthyl azide. | Q36535622 | ||
| Ethical issues in field trials of genetically modified disease-resistant mosquitoes | Q36750931 | ||
| An essential role of antibodies in the control of Chikungunya virus infection | Q36914762 | ||
| Larvivorous fish including Gambusia | Q36939863 | ||
| The Chikungunya threat: an ecological and evolutionary perspective | Q37055716 | ||
| Mosquito control by larvivorous fish. | Q37100718 | ||
| The threat of chikungunya in Oceania | Q37146919 | ||
| Chikungunya: a review | Q37153380 | ||
| Chikungunya: a paradigm of emergence and globalization of vector-borne diseases | Q37343061 | ||
| Chikungunya fever: an epidemiological review of a re-emerging infectious disease | Q37575480 | ||
| Immuno-biology of Chikungunya and implications for disease intervention | Q37593713 | ||
| A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infection. | Q37643733 | ||
| Potential of Aedes aegypti and Aedes albopictus populations in the Central African Republic to transmit enzootic chikungunya virus strains | Q37724350 | ||
| Genetic control of Aedes mosquitoes | Q37726480 | ||
| Biological Control Strategies for Mosquito Vectors of Arboviruses | Q37728092 | ||
| Laboratory diagnosis of chikungunya virus: do we really need it? | Q38068325 | ||
| Chikungunya virus: an update on antiviral development and challenges | Q38107673 | ||
| Chikungunya fever: epidemiology, clinical syndrome, pathogenesis and therapy | Q38118022 | ||
| Mosquito control with green nanopesticides: towards the One Health approach? A review of non-target effects | Q38157261 | ||
| Imipramine Inhibits Chikungunya Virus Replication in Human Skin Fibroblasts through Interference with Intracellular Cholesterol Trafficking | Q38158924 | ||
| Emerging alphaviruses in the Americas: Chikungunya and Mayaro | Q38334478 | ||
| Prevalence of antibodies to alphaviruses and flaviviruses in free-ranging game animals and nonhuman primates in the greater Congo basin | Q38396005 | ||
| Sterile insect technique: targeted control without insecticide | Q38458353 | ||
| Plant-borne ovicides in the fight against mosquito vectors of medical and veterinary importance: a systematic review | Q38560314 | ||
| Early Guillain-Barré Syndrome associated with acute dengue fever | Q38741098 | ||
| Long-lasting effects of a Bacillus thuringiensis serovar israelensis experimental tablet formulation for Aedes aegypti (Diptera: Culicidae) control | Q38879774 | ||
| Neutralization Assay for Chikungunya Virus Infection: Plaque Reduction Neutralization Test | Q38885699 | ||
| Chikungunya virus in the Entebbe area of Uganda: isolations and epidemiology | Q38896042 | ||
| The occurrence of Chikungunya virus in Uganda. I. Isolation from mosquitoes | Q38899220 | ||
| Evaluation of mosquito fish Gambusia affinis in the control of mosquito breeding in rice fields | Q44144134 | ||
| Entomopathogenic fungi as the next-generation control agents against malaria mosquitoes | Q44150177 | ||
| Acute toxicity and synergistic and antagonistic effects of the aromatic compounds of some essential oils against Culex quinquefasciatus Say larvae | Q44150825 | ||
| Antibody against Chikungunya virus in wild primates in Southern Africa | Q44156785 | ||
| Fungal pathogen reduces potential for malaria transmission | Q44164916 | ||
| Development of an attenuated strain of chikungunya virus for use in vaccine production | Q44523303 | ||
| Clinical characterization of acute and convalescent illness of confirmed chikungunya cases from Chiapas, S. Mexico: A cross sectional study | Q44843642 | ||
| Systemic involvements and fatalities during Chikungunya epidemic in India, 2006. | Q44850657 | ||
| Persistent arthralgia associated with chikungunya virus: a study of 88 adult patients on reunion island | Q44851009 | ||
| Chikungunya and respiratory viral infections | Q44851176 | ||
| Molecular and serological diagnosis of Chikungunya virus infection | Q44851228 | ||
| Guillain-Barré syndrome and Epstein-Barr virus | Q45827010 | ||
| Persistence of virulent Semliki Forest virus in mouse brain following co-inoculation with defective interfering particles | Q45836748 | ||
| Experimental mass-rearing of the mosquitofish, Gambusia affinis | Q46518436 | ||
| Co-circulation and simultaneous co-infection of dengue, chikungunya, and zika viruses in patients with febrile syndrome at the Colombian-Venezuelan border | Q47547831 | ||
| Management of arthropod vector data - Social and ecological dynamics facing the One Health perspective | Q49897134 | ||
| Venereal transmission of chikungunya virus by Aedes aegypti mosquitoes (Diptera: Culicidae) | Q34341802 | ||
| Seroprevalence survey of Chikungunya virus in Bagan Panchor, Malaysia | Q34341808 | ||
| Chikungunya virus infection: an overview | Q34361644 | ||
| Cytokines in acute chikungunya | Q34400952 | ||
| Simple clinical and laboratory predictors of Chikungunya versus dengue infections in adults | Q34431514 | ||
| Eradication of Aedes aegypti from a village in Vietnam, using copepods and community participation. | Q34477244 | ||
| Evolutionary influences in arboviral disease | Q34506254 | ||
| Inhibition of chikungunya virus replication by harringtonine, a novel antiviral that suppresses viral protein expression | Q34527618 | ||
| The combination of the entomopathogenic fungus Metarhizium anisopliae with the insecticide Imidacloprid increases virulence against the dengue vector Aedes aegypti (Diptera: Culicidae). | Q34569666 | ||
| Infectious clones of Chikungunya virus (La Réunion isolate) for vector competence studies | Q34594476 | ||
| A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritis | Q34703785 | ||
| Fitness of transgenic mosquito Aedes aegypti males carrying a dominant lethal genetic system. | Q34729857 | ||
| Susceptibility of adult female Aedes aegypti (Diptera: Culicidae) to the entomopathogenic fungus Metarhizium anisopliae is modified following blood feeding | Q35084301 | ||
| Predation efficiency of Anopheles gambiae larvae by aquatic predators in western Kenya highlands | Q35122414 | ||
| Case reports of neuro-Chikungunya in southern Thailand | Q35131464 | ||
| Recombinant modified vaccinia virus Ankara expressing glycoprotein E2 of Chikungunya virus protects AG129 mice against lethal challenge | Q35238179 | ||
| Chikungunya virus: evolution and genetic determinants of emergence | Q35240173 | ||
| Combining the sterile insect technique with the incompatible insect technique: I-impact of wolbachia infection on the fitness of triple- and double-infected strains of Aedes albopictus | Q35304268 | ||
| Direct and indirect effect of predators on Anopheles gambiae sensu stricto | Q35464470 | ||
| One year after the Zika virus outbreak in Brazil: from hypotheses to evidence | Q27787431 | ||
| Prolonged shedding of Chikungunya virus in semen and urine: A new perspective for diagnosis and implications for transmission | Q27926247 | ||
| Dengue, Zika and Chikungunya: Emerging Arboviruses in the New World | Q28073453 | ||
| Mosquito repellents: An insight into the chronological perspectives and novel discoveries | Q28114529 | ||
| Chikungunya virus and the global spread of a mosquito-borne disease | Q28259416 | ||
| Identification of prohibitin as a Chikungunya virus receptor protein | Q28275508 | ||
| A Review of Chikungunya Virus-induced Arthralgia: Clinical Manifestations, Therapeutics, and Pathogenesis | Q28353979 | ||
| A chikungunya fever vaccine utilizing an insect-specific virus platform | Q28954709 | ||
| Infection with chikungunya virus in Italy: an outbreak in a temperate region | Q29346487 | ||
| Point of sampling detection of Zika virus within a multiplexed kit capable of detecting dengue and chikungunya | Q29571481 | ||
| The wMel Wolbachia strain blocks dengue and invades caged Aedes aegypti populations | Q29616260 | ||
| Impact of simultaneous exposure to arboviruses on infection and transmission by Aedes aegypti mosquitoes | Q30145591 | ||
| Chikungunya virus: epidemiology, replication, disease mechanisms, and prospective intervention strategies | Q30235512 | ||
| Chikungunya: Its History in Africa and Asia and Its Spread to New Regions in 2013-2014. | Q30240215 | ||
| Vectors of Chikungunya virus in Senegal: current data and transmission cycles | Q30559453 | ||
| In vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds: synergistic effect of interferon-alpha and ribavirin combination | Q33195882 | ||
| Outbreak of chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients | Q33375141 | ||
| Congenital chikungunya | Q33410266 | ||
| Simultaneous detection of chikungunya virus, dengue virus and human pathogenic Leptospira genomes using a multiplex TaqMan® assay | Q33634555 | ||
| The cholesterol requirement for sindbis virus entry and exit and characterization of a spike protein region involved in cholesterol dependence | Q33647933 | ||
| Chikungunya vaccine candidate is highly attenuated and protects nonhuman primates against telemetrically monitored disease following a single dose. | Q33684369 | ||
| Epidemiology, clinical manifestations, and diagnosis of Chikungunya fever: lessons learned from the re-emerging epidemic | Q33796693 | ||
| High level of vector competence of Aedes aegypti and Aedes albopictus from ten American countries as a crucial factor in the spread of Chikungunya virus | Q33887791 | ||
| Insecticide resistance in insect vectors of human disease | Q33889711 | ||
| Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218. | Q33942533 | ||
| Evidence of experimental vertical transmission of emerging novel ECSA genotype of Chikungunya Virus in Aedes aegypti | Q33981774 | ||
| Genome-scale phylogenetic analyses of chikungunya virus reveal independent emergences of recent epidemics and various evolutionary rates | Q33990566 | ||
| Neurological complications in Chikungunya fever. | Q34010040 | ||
| On chikungunya acute infection and chloroquine treatment | Q34012738 | ||
| Clinical progression of chikungunya fever during acute and chronic arthritic stages and the changes in joint morphology as revealed by imaging | Q34099818 | ||
| Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response | Q34110965 | ||
| Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays | Q34113650 | ||
| Sterile-insect methods for control of mosquito-borne diseases: an analysis | Q34157662 | ||
| An epidemic of virus disease in Southern Province, Tanganyika territory, in 1952–1953 II. General description and epidemiology | Q34261544 | ||
| Attenuation of Chikungunya virus vaccine strain 181/clone 25 is determined by two amino acid substitutions in the E2 envelope glycoprotein | Q34264257 | ||
| Current vector control challenges in the fight against malaria | Q38903425 | ||
| Laboratory Diagnosis of Chikungunya Virus Infections and Commercial Sources for Diagnostic Assays | Q39128579 | ||
| Co-Infection of Mosquitoes with Chikungunya and Dengue Viruses Reveals Modulation of the Replication of Both Viruses in Midguts and Salivary Glands of Aedes aegypti Mosquitoes | Q39164174 | ||
| Guillain-Barré Syndrome due to CMV Reactivation after Cardiac Transplantation | Q39174434 | ||
| Corticosteroid therapy in an alphaviral arthritis | Q39286438 | ||
| Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial | Q39382188 | ||
| Bacillus thuringiensis var. israelensis (Bti) provides residual control of Aedes aegypti in small containers | Q39400224 | ||
| Evaluation of Costa Rican copepods (Crustacea: Eudecapoda) for larval Aedes aegypti control with special reference to Mesocyclops thermocyclopoides | Q39435243 | ||
| Green-synthesized silver nanoparticles as a novel control tool against dengue virus (DEN-2) and its primary vector Aedes aegypti | Q39496847 | ||
| Replicon vectors derived from Sindbis virus and Semliki forest virus that establish persistent replication in host cells | Q39593506 | ||
| Guillain-Barré Syndrome and Human Immunodeficiency Virus. | Q39639984 | ||
| Inhibition of Chikungunya virus infection in cultured human muscle cells by furin inhibitors: impairment of the maturation of the E2 surface glycoprotein | Q39971773 | ||
| Simultaneous detection of Zika, Chikungunya and Dengue viruses by a multiplex real-time RT-PCR assay | Q40054954 | ||
| Chikungunya virus: clinical aspects and treatment - A Review | Q40098030 | ||
| Evidence for natural vertical transmission of chikungunya viruses in field populations of Aedes aegypti in Delhi and Haryana states in India-a preliminary report | Q40102007 | ||
| Increase in cases of Guillain-Barré syndrome during a Chikungunya outbreak, French Polynesia, 2014 to 2015. | Q40126017 | ||
| Assessment of flavaglines as potential chikungunya virus entry inhibitors | Q40171382 | ||
| Risk factors for symptomatic and asymptomatic chikungunya infection | Q40233960 | ||
| A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus | Q40245153 | ||
| Modelling Aedes aegypti mosquito control via transgenic and sterile insect techniques: endemics and emerging outbreaks | Q40250380 | ||
| Viremic profiles in asymptomatic and symptomatic chikungunya fever: a blood transfusion threat? | Q40267017 | ||
| Utility of IgM ELISA, TaqMan real-time PCR, reverse transcription PCR, and RT-LAMP assay for the diagnosis of Chikungunya fever | Q40273691 | ||
| Neuromuscular manifestations of west nile virus infection | Q40291825 | ||
| Mosquitocidal activity of Solanum xanthocarpum fruit extract and copepod Mesocyclops thermocyclopoides for the control of dengue vector Aedes aegypti. | Q40293891 | ||
| Vector control for the Chikungunya disease. | Q40358902 | ||
| Severe bullous skin lesions associated with Chikungunya virus infection in small infants | Q40391182 | ||
| Community-based use of the larvivorous fish Poecilia reticulata to control the dengue vector Aedes aegypti in domestic water storage containers in rural Cambodia | Q40412178 | ||
| Atypical Chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005-2006 outbreak on Réunion | Q40412307 | ||
| Evaluation of the first commercial chikungunya virus indirect immunofluorescence test | Q40426409 | ||
| Seroprevalence of Chikungunya virus (CHIKV) infection on Lamu Island, Kenya, October 2004. | Q40427692 | ||
| Efficacy of fish as predators of Aedes aegypti larvae, under laboratory conditions | Q40446366 | ||
| Seroprevalence of Chikungunya virus infection on Grande Comore Island, union of the Comoros, 2005. | Q40447818 | ||
| Evaluation of Caribbean strains of Macrocyclops and Mesocyclops (Cyclopoida:Cyclopidae) as biological control tools for the dengue vector Aedes aegypti. | Q40654238 | ||
| Chikungunya Virus Vaccine Prepared by Tween-Ether Extraction | Q40712673 | ||
| Status of research and development of vaccines for chikungunya | Q40736589 | ||
| Campylobacter jejuni capsular genotypes are related to Guillain-Barré syndrome | Q41164424 | ||
| S argassum muticum-synthesized silver nanoparticles: an effective control tool against mosquito vectors and bacterial pathogens | Q41373897 | ||
| Chloroquine phosphate treatment of chronic Chikungunya arthritis. An open pilot study | Q41918756 | ||
| Guillain-Barré Syndrome Associated With Zika Virus Infection in Martinique in 2016: A Prospective Study | Q41919087 | ||
| Chikungunya Virus-Associated Disease | Q41923135 | ||
| Assessment of in vitro prophylactic and therapeutic efficacy of chloroquine against Chikungunya virus in vero cells | Q41936262 | ||
| Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial | Q42199381 | ||
| Mild form of Guillain-Barré syndrome in a patient with primary Epstein-Barr virus infection | Q42374514 | ||
| Chikungunya disease outbreak, Reunion Island. | Q42616934 | ||
| Atypical chikungunya virus infections in immunocompromised patients | Q42725689 | ||
| Evaluation of slow-release formulations of temephos (Abate) and Bacillus thuringiensis var. israelensis for the control of Aedes aegypti in Puerto Rico. | Q42989002 | ||
| Mesocyclops longisetus effects on survivorship of Aedes aegypti immature stages in car tyres. | Q42990957 | ||
| Development of a quantitative competitive reverse transcription polymerase chain reaction (QC-RT-PCR) for detection and quantitation of Chikungunya virus | Q42993938 | ||
| Aedes albopictus control with spray application of Bacillus thuringiensis israelensis, strain AM 65-52 | Q43001470 | ||
| Assessment of immunogenic potential of Vero adapted formalin inactivated vaccine derived from novel ECSA genotype of Chikungunya virus | Q43511956 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | epidemiology | Q133805 |
| parasitology | Q180502 | ||
| chikungunya | Q243257 | ||
| Chikungunya virus | Q15794049 | ||
| infectious disease | Q18123741 | ||
| scoping review | Q101116078 | ||
| co-circulation | Q128147068 | ||
| P304 | page(s) | 213-224 | |
| P577 | publication date | 2018-12-01 | |
| P1433 | published in | Acta Tropica | Q15762560 |
| P1476 | title | A scoping review of Chikungunya virus infection: epidemiology, clinical characteristics, viral co-circulation complications, and control | |
| P478 | volume | 188 |
| Q60310690 | Adult immunization – Need of the hour |
| Q63246513 | Analysis of Salivary Glands and Saliva from and Infected with Chikungunya Viruses |
| Q93161303 | Beyond Fever and Pain: Diagnostic Methods for Chikungunya Virus |
| Q96124071 | Chikungunya vaccine: a single shot for a long protection? |
| Q97568990 | Development of magnetic bead based sample extraction coupled polymerase spiral reaction for rapid on-site detection of Chikungunya virus |
| Q93087252 | Rheumatic manifestations of chikungunya: emerging concepts and interventions |
| Q92258069 | Serological Data Shows Low Levels of Chikungunya Exposure in Senegalese Nomadic Pastoralists |
| Q92640434 | Travel-associated chikungunya acquired in Myanmar in 2019 |
| Q62737885 | Tropism of the Chikungunya Virus |
Search more.